| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |